Imatinib Mesylate and Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer

NCT00045604 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: cisplatin
DRUG: imatinib mesylate
DRUG: irinotecan hydrochloride

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]